Thomas P C Dorlo (T P C Dorlo, Thomas Dorlo)

ResearcherID Loop profile Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Venues

CPT: pharmacometrics & systems pharmacology

The Journal of antimicrobial chemotherapy

PLoS neglected tropical diseases

Clinical and translational science

Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

University of Amsterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis Dec 01 2016

Netherlands

Senior Scientist / Pharmacometrician :: Pharmacy & Pharmacology

Uppsala Universitet

Sweden

Researcher :: Dept. Pharmaceutical Biosciences

Utrecht University

Netherlands

Lecturer :: Div. Pharmacoepidemiology & Clinical Pharmacology

Education History

University of Amsterdam

Netherlands

PHD :: Tropical Medicine

Utrecht University

Netherlands

MSC :: Pharmaceutical Sciences

Utrecht University

Netherlands

BSC :: Pharmaceutical Sciences

Publications

Luka Verrest, Séverine Monnerat, Ahmed M Musa, Jane Mbui, Eltahir A G Khalil, Joseph Olobo, Monique Wasunna, Wan-Yu Chu, Alwin D R Huitema, Henk D F H Schallig, Fabiana Alves, Thomas P C Dorlo
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model. PLoS neglected tropical diseases 18 (4) (2024)
Semra Palić, Wan-Yu Chu, Shyam Sundar, Dinesh Mondal, Pradeep Das, Krishna Pandey, Sheeraz Raja, Suman Rijal, Ignace C Roseboom, Abdullah Hamadeh, Paul R V Malik, Jos H Beijnen, Alwin D R Huitema, Erik Sjögren, Fabiana Alves, Thomas P C Dorlo
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Luka Verrest, Séverine Monnerat, Ahmed M Musa, Jane Mbui, Eltahir A G Khalil, Joseph Olobo, Monique Wasunna, Wan-Yu Chu, Alwin D R Huitema, Henk D F H Schallig, Fabiana Alves, Thomas P C Dorlo
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model. PLoS neglected tropical diseases 18 (4) (2024)
Semra Palić, Wan-Yu Chu, Shyam Sundar, Dinesh Mondal, Pradeep Das, Krishna Pandey, Sheeraz Raja, Suman Rijal, Ignace C Roseboom, Abdullah Hamadeh, Paul R V Malik, Jos H Beijnen, Alwin D R Huitema, Erik Sjögren, Fabiana Alves, Thomas P C Dorlo
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Wan-Yu Chu, Luka Verrest, Brima M Younis, Ahmed M Musa, Jane Mbui, Rezika Mohammed, Joseph Olobo, Koert Ritmeijer, Séverine Monnerat, Monique Wasunna, Ignace C Roseboom, Alexandra Solomos, Alwin D R Huitema, Fabiana Alves, Thomas P C Dorlo
Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in eastern Africa. The Journal of infectious diseases (2024)
Semra Palić, Wan-Yu Chu, Shyam Sundar, Dinesh Mondal, Pradeep Das, Krishna Pandey, Sheeraz Raja, Suman Rijal, Ignace C Roseboom, Abdullah Hamadeh, Paul R V Malik, Jos H Beijnen, Alwin D R Huitema, Erik Sjögren, Fabiana Alves, Thomas P C Dorlo
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Luka Verrest, Séverine Monnerat, Ahmed M Musa, Jane Mbui, Eltahir A G Khalil, Joseph Olobo, Monique Wasunna, Wan-Yu Chu, Alwin D R Huitema, Henk D F H Schallig, Fabiana Alves, Thomas P C Dorlo
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model. PLoS neglected tropical diseases 18 (4) (2024)
Luka Verrest, Séverine Monnerat, Ahmed M Musa, Jane Mbui, Eltahir A G Khalil, Joseph Olobo, Monique Wasunna, Wan-Yu Chu, Alwin D R Huitema, Henk D F H Schallig, Fabiana Alves, Thomas P C Dorlo
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model. PLoS neglected tropical diseases 18 (4) (2024)
Semra Palić, Wan-Yu Chu, Shyam Sundar, Dinesh Mondal, Pradeep Das, Krishna Pandey, Sheeraz Raja, Suman Rijal, Ignace C Roseboom, Abdullah Hamadeh, Paul R V Malik, Jos H Beijnen, Alwin D R Huitema, Erik Sjögren, Fabiana Alves, Thomas P C Dorlo
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Semra Palić, Wan-Yu Chu, Shyam Sundar, Dinesh Mondal, Pradeep Das, Krishna Pandey, Sheeraz Raja, Suman Rijal, Ignace C Roseboom, Abdullah Hamadeh, Paul R V Malik, Jos H Beijnen, Alwin D R Huitema, Erik Sjögren, Fabiana Alves, Thomas P C Dorlo
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia. The Journal of antimicrobial chemotherapy (2024)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
David Damoiseaux, Alfred H Schinkel, Jos H Beijnen, Alwin D R Huitema, Thomas P C Dorlo
Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis. Clinical and translational science (2023)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
David Damoiseaux, Frédéric Amant, Jos H Beijnen, Shelby Barnett, Gareth J Veal, Alwin D R Huitema, Thomas P C Dorlo
Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk. CPT: pharmacometrics & systems pharmacology (2023)
Lisa T van der Heijden, N Steeghs, J H Beijnen, A D R Huitema, Thomas P C Dorlo
The use of microtracers in food-effect trials: An alternative study design for toxic drugs with long half-lives exemplified by the case for alectinib. Clinical and translational science (2023)
Wan-Yu Chu, Thomas P C Dorlo
Comment on "Dosing implications for liposomal amphotericin B in pregnancy". Pharmacotherapy 43 (9) (2023)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology (2023)
Hinke Siebinga, Bastiaan M Privé, Steffie M B Peters, James Nagarajah, Thomas P C Dorlo, Alwin D R Huitema, Berlinda Jantina de Wit-van der Veen, Jeroen J M A Hendrikx
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177 Lu-PSMA-617 in prostate cancer patients. CPT: pharmacometrics & systems pharmacology (2023)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Simon E Koele, Thomas P C Dorlo, Caryn M Upton, Rob E Aarnoutse, Elin M Svenson
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling. CPT: pharmacometrics & systems pharmacology 13 (3) (2023)
Lisa T van der Heijden, Merel van Nuland, Jos Beijnen, Alwin Huitema, Thomas P C Dorlo
A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens. Clinical and translational science (2022)
Julie M Janssen, Remy B Verheijen, Tirsa T van Duijl, Lishi Lin, Michel M van den Heuvel, Jos H Beijnen, Neeltje Steeghs, Daan van den Broek, Alwin D R Huitema, Thomas P C Dorlo
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR-mutant non-small cell lung cancer. Clinical and translational science 15 (8) (2022)
Jurgen B Langenhorst, Thomas P C Dorlo, Charlotte van Kesteren, Erik M van Maarseveen, Stefan Nierkens, Moniek A de Witte, Jaap Jan Boelens, Alwin D R Huitema
Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation. CPT: pharmacometrics & systems pharmacology 9 (5) (2020)
Marie-Rose B S Crombag, Thomas P C Dorlo, Ellen van der Pan, Anoek van Straten, Andries M Bergman, Nielka P van Erp, Jos H Beijnen, Alwin D R Huitema
Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study. Pharmaceutical research 36 (12) (2019)
Luka Verrest, Thomas P C Dorlo
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review. Clinical pharmacokinetics 56 (6) (2018)
Jesmin Permala, Stephen Rulisa, Peter J de Vries, Petra F Mens, Nadine Kaligirwa, Steven Agaba, Joel Tarning, Mats O Karlsson, Thomas P C Dorlo
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria. Antimicrobial agents and chemotherapy 62 (10) (2018)
Thomas P C Dorlo, Carmen Fernández, Marita Troye-Blomberg, Peter J de Vries, Diana Boraschi, Wilfred F Mbacham
Poverty-Related Diseases College: a virtual African-European network to build research capacity. BMJ global health 1 (1) (2016)

Thomas P C Dorlo.css-eqlu8i{font-size:small;padding-left:4px;} (T P C Dorlo, Thomas Dorlo)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas P C Dorlo (T P C Dorlo, Thomas Dorlo)